Abbott Receives Positive Opinion for HUMIRA in Ulcerative Colitis from EMA's CHMP
Positive Opinion Based on Supporting Data from Two Phase III Clinical Studies
22-Feb-2012 -
Abbott announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for HUMIRA® (adalimumab) in adults with moderate to severely active ulcerative colitis (UC) who have not responded to, cannot tolerate or have medical contraindications to ...
Abbott
inflammatory bowel disease
ulcerative colitis